Newly formed data science group created from XClinical, Carenity, and Fortress Medical, to rename as EvidentIQ Group, and brings two life science veterans onboard

The newly formed life science group that resulted from the merger of clinical software vendors XClinical and Fortress Medical with social platform Carenity, announced to rename itself to EvidentIQ Group.

The EvidentIQ offering brings an innovative end to end eClinical solution that meets increasing customer demand across clinical operations and clinical data management needs with its suite of applications, including EDC, coding, remote monitoring, RBM ePRO, eTMF, CTMS, RTMS, Payments and eFeasibility within a single integrated cloud platform. By combining the platform with a broad data science service portfolio such as patient recruitment, patient engagement media and a host of RWE late phase solutions EvidentIQ significantly helps customers optimize HTA submissions, pricing and reimbursement needs.

Andreas Weber appointed new CEO

Today it was announced that Andreas Weber has been appointed CEO of EvidentIQ, leading the group’s strategy and operations. Andreas brings in more than 20 years of industry experience and looks back on a career with top management positions at ERT, Bioclinica and Oracle Health Sciences.

In a statement to disclose the new name and future positioning of the group, Weber said:

“By evolving into a next generation technology amplified data science group, EvidentIQ is paving the way for a new standard in value creation and innovation driven relevance for its customers.”

“Our customers across XClinical, Carenity and Fortress Medical are at the heart of everything we do. As such, I wanted to assure our current loyal and valued customers, that not only will we continue the existing solutions and support offerings, we will in fact be expanding them technologically as well as increasing their interoperability.”

Lewis Baird to take over CCO role

Seconding Mr. Weber, Lewis Baird will take over the sales responsibility as Chief Commercial Officer with EvidentIQ. Before joining EvidentIQ, Lewis established and led the European commercial team at Medrio. Prior to Medrio, Lewis held commercial leadership roles at DataTrial, Biorasi and Quintiles.

Together with Manuel Neukum (Chief Operations Officer), Michael Chekroun (Chief Strategy and Transformation Officer) and Roland Hiltmann (Chief Financial Officer), Lewis is part of Andreas Weber’s Executive Management Team.

Today EvidentIQ already supports 7 of the top 10 pharma companies through novel RWE solutions and 150+ SMB customers in over 20 countries, including US, Germany, France, UK, Italy, Japan and China.

Über die XClinical GmbH

EvidentIQ is a next generation technology-amplified data science group championing new standards in value creation and innovation driven relevance for customers. The EvidentIQ offering brings a pioneering end to end eClinical solution that meets increasing customer demand across clinical operations and clinical data management needs with a suite of applications within a single integrated cloud platform. By combining its platform with a broad data science service portfolio such as patient recruitment, patient engagement media and a host of RWE late phase solutions EvidentIQ significantly helps customers optimize HTA submissions, pricing and reimbursement needs.

EvidentIQ supports 7 of the top 10 pharma companies through novel RWE solutions and 150+ SMB customers in over 20 countries, including US, Germany, France, UK, Italy, Japan and China.

Firmenkontakt und Herausgeber der Meldung:

XClinical GmbH
Arnulfstraße 19
80335 München
Telefon: +49 (89) 4522775000
Telefax: +49 (89) 4522775900
https://www.xclinical.com

Ansprechpartner:
Mark Muschelknautz
Telefon: +49 (1520) 6225307
E-Mail: mark.muschelknautz@xclinical.com
Für die oben stehende Pressemitteilung ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel